研究論文（111.01～111.12)
| 篇序 |
作者 |
論文題目 | 發表雜誌名稱 (含年月/卷期/頁次) |
屬性 (SCI、SSCI、IEEE) |
|---|---|---|---|---|
| 1 |
許銘仁(1) |
Validation of coding algorithms for identifying people with viral hepatitis using claims data according to different standard references |
BMC Infectious Diseases volume 22, Article number: 222 (2022) |
SCI |
| 2 |
古關光浩(1) 許銘仁(1) |
Eradication therapy may decrease the risk of immune thrombocytopenia after Helicobacter pylori infection: a retrospective cohort study in Taiwan |
BMC Gastroenterology 2023 23:36 |
SCI |
| 3 |
許銘仁(1) |
Betanin-enriched red beet extract inhibits the inflammatory response in LPS-induced RAW264.7 cells through NF-kB and MAPK signaling pathways |
Journal of Functional Foods Submitted(2023) |
SCI |
| 4 | 吳佩叡(1) 郭行道(2) 許銘仁(C) |
Clinical Characteristics, Imaging Features, and Outcomes of Primary Hepatic Angiosarcoma: A Single-Center Experience and Review of Literature | Advances in Digestive Medicine Submitted(2023-02) | |
| 5 | 郭行道(C) | Benefits of stronger Neo-Minophagen C in acute hepatitis after transarterial Chemoembolization therapy for hepatomas | Adv Dig Med. 2022;1–7 | |
| 6 | 郭行道(C) | Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients. | PLoS One. 2022 May 13;17(5):e0268180 | SCI |
| 7 | 郭行道(9) | Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals |
Viruses . 2022 Feb 7;14(2):333. |
SCI |
| 8 | 郭行道(6) | Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan |
J Formos Med Assoc . 2022 Aug;121(8):1567-1578. |
SCI |
| 9 | 郭行道(6) | Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan |
Infect Dis Ther . 2022 Feb;11(1):485-500 |
SCI |
| 10 | 郭行道(8) | Comparison of the risk of gastrointestinal perforation between patients with and without rheumatoid arthritis: A nationwide cohort study in Asia |
Front Med (Lausanne) . 2022 Sep 29;9:974328. |
SCI |
| 11 | 郭行道(12) | Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR) |
Clin Gastroenterol Hepatol . 2022 May;20(5):1151-1162. |
SCI |
| 12 | 郭行道(12) | A Phase 3 clinical trial validating the potency and safety of an innovative, extra-long-acting interferon in chronic hepatitis C | JGH Open. 2022 Oct 10;6(11):782-791. | SCI |
| 13 | 郭行道(6) | Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study |
Am J Cancer Res . 2022 Jul 15;12(7):3164-3174. |
SCI |
| 14 | 郭行道(6) | Long-term outcome of liver complications in patients with chronic hbv/hcv co-infection after antiviral therapy: a real-world nationwide study on taiwanese chronic hepatitis c cohort (T-COACH) | HEPATOL INTVol 15/NO 05/P 1109-1121 | SCI |
| 15 | 郭行道(5) | 尿毒性心包膜炎和透析相關的心包膜炎 |
內科學誌 Vol 32/NO 3/P 151-159 |
|
| 16 |
吳佩叡(1) 馮意哲(C) |
Iatrogenic Kaposi sarcoma of the small bowel in Crohn’s disease following short-term use of immunomodulators: a case report and review of the literature. | Journal of Medical Case Reports, 07 Nov 2022, 16(1):424. | ESCI |
| 17 | 馮意哲(1) | Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents | Journal Of Microbiology Immunology And Infection Vol 22/NO /P 00095 | SCI |
| 18 |
陳建宏(1) 馮意哲(C) |
Mixed neuroendocrine-non-neuroendocrine neoplasms of the ampulla of Vater: A case report and literature review | Advances in digest ive medicine 2022;1–5. | |
| 19 | 陳奕嘉(1) | Association of hepatitis C virus infection status and genotype with kidney disease risk: A population-based cross-sectional study | PLoS ONE 17(7): e0271197. | SCI |